These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 37171542)

  • 1. SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study.
    Zivelonghi C; Dinoto A; Irani SR; McKeon A; Pilotto A; Padovani A; Masciocchi S; Magni E; Mancinelli CR; Capra R; Maniscalco GT; Volonghi I; Easton A; Alberti D; Zanusso G; Monaco S; Salvagno GL; Lippi G; Ferrari S; Mariotto S
    Immunol Res; 2023 Oct; 71(5):717-724. PubMed ID: 37171542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.
    Valencia Sanchez C; Theel E; Binnicker M; Toledano M; McKeon A
    Neurology; 2021 Dec; 97(23):e2262-e2268. PubMed ID: 34635560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Bolton MJ; Arevalo CP; Anderson EM; Goodwin EC; Hensley SE; Puopolo KM
    JAMA Pediatr; 2021 Jun; 175(6):594-600. PubMed ID: 33512440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Seroconversion in Children and Adults With Mild COVID-19.
    Toh ZQ; Anderson J; Mazarakis N; Neeland M; Higgins RA; Rautenbacher K; Dohle K; Nguyen J; Overmars I; Donato C; Sarkar S; Clifford V; Daley A; Nicholson S; Mordant FL; Subbarao K; Burgner DP; Curtis N; Bines JE; McNab S; Steer AC; Mulholland K; Tosif S; Crawford NW; Pellicci DG; Do LAH; Licciardi PV
    JAMA Netw Open; 2022 Mar; 5(3):e221313. PubMed ID: 35262717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.
    Nersesjan V; Amiri M; Nilsson AC; Wamberg C; Jensen VVS; Petersen CB; Hejl AM; Lebech AM; Theut AM; Jørgensen CS; Blaabjerg M; Benros ME; Kondziella D
    Brain Commun; 2023; 5(5):fcad274. PubMed ID: 37908236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory SARS-CoV-2 T-cell response in convalescent COVID-19 patients with undetectable specific IgG antibodies: a comparative study.
    Fernández-Moreno R; Valle-Arroyo J; Páez-Vega A; Salinas A; Cano A; Pérez AB; Torre-Cisneros J; Cantisán S
    Front Immunol; 2023; 14():1142918. PubMed ID: 37180143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients.
    Chong Y; Ikematsu H; Tani N; Arimizu Y; Watanabe H; Fukamachi Y; Yonekawa A; Iwasaka S; Nishida R; Eriguchi Y; Miyake N; Shimoda S; Nagasaki Y; Shimono N; Akashi K
    Influenza Other Respir Viruses; 2021 Jan; 15(1):13-18. PubMed ID: 32909661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.
    Amellal H; Assaid N; Charoute H; Akarid K; Maaroufi A; Ezzikouri S; Sarih M
    PLoS One; 2023; 18(7):e0288557. PubMed ID: 37437051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
    Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
    Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epidemiological and retrospective study in a cohort qualified for SARS-CoV-2 vaccination in the region of Lower Silesia, Poland.
    Stępień M; Świątoniowska-Lonc N; Knysz B; Jankowska-Polańska B; Kuźniarski A; Piwowar A; Zalewska M
    Adv Clin Exp Med; 2023 Mar; 32(3):385-389. PubMed ID: 36920261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2.
    Ye X; Angelo LS; Nicholson EG; Iwuchukwu OP; Cabral de Rezende W; Rajan A; Aideyan LO; McBride TJ; Bond N; Santarcangelo P; Rayford YJ; Ferlic-Stark L; Fragoso S; Momin Z; Liu H; Truong K; Lopez B; Conner ME; Rice AP; Kimata JT; Avadhanula V; Piedra PA
    Front Immunol; 2021; 12():693462. PubMed ID: 34691016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seric IgG anti-SARS-CoV-2 pre- and post- Covid-19 pandemic from Mexican asymptomatic subjects.
    Aguirre-Cruz L; Guzmán-García M; Acosta-Castillo I; De la Cruz-Aguilera DL; Landero-Isidro I; Pérez-González JP; Chávez-Duarte J; Leyva-Rendón A
    Salud Publica Mex; 2022 Jun; 64(3, may-jun):249-258. PubMed ID: 36130393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
    Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
    J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
    Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
    J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
    Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
    Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
    Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of IgM, IgG, IgA and neutralizing antibody responses to SARS-CoV-2 infection and mRNA vaccination.
    Fleischmann CJ; Bulman CA; Yun C; Lynch KL; Wu AHB; Whitman JD
    J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.